戻る Agenda
Session 6B: Risk-based Approach to Monitoring CR
Speaker(s)
Risk-based Approach to Monitoring CR
Sunita Zalani, PHD
Merck & Co., Inc., United States
Vice President, Regulatory Affairs, Oncology
Risk-based Approach to Monitoring CR
Chirag Trivedi
Sanofi India Limited, India
Director, Clinical Study Unit,